Arkolith/Insider Trading/UPXI/Form 4

Salkind Gene

Director, 10% OwnerUPEXI, INC. (UPXI) · full profile →Form 4 · filed Apr 25, 2025
Net Buying
Open-Market Buys
$550K
Open-Market Sells
$0
Net Open-Market Flow
$550K
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 17, 2025Buy(P)241K$2.28$550K365K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 17, 2025Grant(A)35K—$035K
Jan 17, 2025Grant(A)25K—$025K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001477932-25-002979) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML